Welcome to BioSeeker Group!

Analytical Tool - Pancreatic Cancer

Additional Information

Published Date Mar 1, 2012
PDF Fact Sheet View Fact Sheet for the report Analytical Tool - Pancreatic Cancer in PDF
Format PDF & Software Application
Publisher BioSeeker Group

Availability: In stock

€3,100.00

Quick Overview

A unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development.
Request free sample pages from Analytical Tool - Pancreatic Cancer

"Analytical Tool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:


The Package Includes

  • A progress analysis on current and emerging drugs
  • Information on most companies active in pancreatic cancer R&D
  • Information on key industry related pancreatic cancer projects
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of pancreatic cancer therapeutics
  • Identifying emerging pancreatic cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of pancreatic cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker’s software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Request free sample pages from Analytical Tool - Pancreatic Cancer

Other selected research from the 'Analytical Tool' category:


Analytical Tool - Lymphoma
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. Learn More


Analytical Tool - Angiogenesis in Oncology
The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More

Other selected research from the 'Oncology' category:


Triple Analysis: Lung Cancer, Pancreatic Cancer and Antibodies
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the compound strategy of Antibodies. Learn More


Triple Analysis: Prostate Cancer, Cancer Vaccines and Antibodies
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). Learn More